Natrijev Klorid Fresenius Kabi (Sodium Chloride)

Sodium Chloride increases the concentration of sodium in the extracellular fluid, raising plasma osmolarity. This osmotic effect draws water from the intracellular space into the bloodstream, expanding intravascular volume, improving tissue perfusion, and restoring normal sodium‑chloride balance essential for nerve and muscle function.

The dose is individualized by the prescribing clinician based on the patient’s fluid status, electrolyte levels, and clinical condition. Healthcare professionals calculate the volume and concentration required to achieve the desired therapeutic effect and adjust it according to ongoing monitoring.

Safety data for sodium chloride injection in pregnancy and lactation are limited. It may be used when clearly needed, but the prescriber must weigh potential benefits against any theoretical risks and consider the mother’s clinical situation before administration.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if required), and necessary import documentation.

Natrijev Klorid is an isotonic sodium chloride injection comparable to other 0.9% saline solutions. Its clinical performance is similar, but differences may exist in manufacturing standards, packaging, and regulatory compliance. GNH India sources the product from an EU‑approved manufacturer, ensuring quality and traceability.

The product must be stored at 2‑8 °C, protected from light, and kept in its original sealed container. Do not freeze or shake the vial. Before use, inspect for particulate matter or discoloration and follow aseptic techniques during preparation and administration.

Natrijev Klorid is administered by intravenous, intramuscular, or subcutaneous injection using sterile technique. The route, rate, and total volume are determined by the prescriber according to the patient’s condition, with continuous monitoring of vital signs and electrolyte levels during infusion.

Serious risks include severe hypernatremia, fluid overload leading to pulmonary edema, and rare allergic reactions such as anaphylaxis. These complications can cause neurological symptoms, respiratory distress, or cardiac arrhythmias and require immediate medical attention.

Patients with known hypersensitivity to sodium chloride, uncontrolled hypernatremia, severe fluid overload, or conditions where rapid volume expansion is contraindicated (e.g., certain heart failures) should not receive this product unless a clinician determines that benefits outweigh the risks.